You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

What Is New With the Flu? Prevention and Treatment for the 2022-2023 Influenza Season

  • Authors: Andrew T. Pavia, MD, FAAP, FACP, FIDSA; Michael G. Ison, MD, MS, FIDSA, FAST; Rachael A. Lee, MD; Leigh Montejo, DNP, FNP-BC
  • CME / ABIM MOC / CE Released: 8/12/2022
  • Valid for credit through: 8/12/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.00 ABIM MOC points

    Nurses - 1.00 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, pediatricians, obstetricians and gynecologists, and nurses.

The goal of this activity is that learners will be better able to keep current of strategies to minimize disease burden and transmission during the 2022-2023 flu season.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Recommendations for antiviral use in treatment and chemoprophylaxis
    • Populations at high risk for influenza-related complications
    • Indications for antiviral use in pediatric populations


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Andrew T. Pavia, MD, FAAP, FACP, FIDSA

    George and Esther Gross Presidential Professor of Pediatrics and Medicine
    Chief, Division of Pediatric Infectious Diseases
    University of Utah
    Director, Hospital Epidemiology Program,
    Primary Children's Hospital
    Salt Lake City, Utah

    Disclosures

    Andrew T. Pavia, MD, FAAP, FACP, FIDSA, has the following relevant financial relationships:
    Consultant or advisor for: GlaxoSmithKline

Faculty

  • Michael G. Ison, MD, MS, FIDSA, FAST

    Professor, Divisions of Infectious Diseases and Organ Transplantation
    Northwestern University Feinberg School of Medicine
    Medical Director, Transplant & Immunocompromised Host Infectious Diseases Service
    Northwestern University Comprehensive Transplant Center
    Director, Center for Clinical Research
    Northwestern University Clinical and Translational Sciences Institute
    Editor-in-Chief, Transplant Infectious Disease Journal
    Chicago, Illinois

    Disclosures

    Michael G. Ison, MD, MS, FIDSA, FAST, has the following relevant financial relationships:
    Consultant or advisor for: Adagio; ADMA Biologics; AlloVir; Atea; Cidara; Genentech/Roche; Janssen; Shionogi; Takeda; Viracor Eurofins
    Research funding from: GlaxoSmithKline; Pulmocide
    Other: DSMB Member/Chair for: Adamis; AlloVir; CSL Behring; Janssen; Merck; Sequiris; Takeda; Talaris

  • Rachael A. Lee, MD

    Associate Professor of Medicine
    Division of Infectious Diseases
    University of Alabama at Birmingham Heersink School of Medicine
    Birmingham, Alabama

    Disclosures

    Rachael A. Lee, MD, has no relevant financial relationships.

  • Leigh Montejo, DNP, FNP-BC

    Assistant Professor
    The Catholic University of America
    Conway School of Nursing
    Washington, DC

    Disclosures

    Leigh Montejo, DNP, FNP-BC, has no relevant financial relationships.

Editor

  • Kalanethee Paul-Pletzer, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Kalanethee Paul-Pletzer, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

What Is New With the Flu? Prevention and Treatment for the 2022-2023 Influenza Season

Authors: Andrew T. Pavia, MD, FAAP, FACP, FIDSA; Michael G. Ison, MD, MS, FIDSA, FAST; Rachael A. Lee, MD; Leigh Montejo, DNP, FNP-BCFaculty and Disclosures

CME / ABIM MOC / CE Released: 8/12/2022

Valid for credit through: 8/12/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Treating the Flu: What Do You Do?

An expert discussion on antiviral use for treatment and chemoprophylaxis.
Andrew T. Pavia, MD, FAAP, FACP, FIDSA; Michael G. Ison, MD, MS, FIDSA, FAST

Influenza and the High-Risk Adult

An expert discussion on populations at high risk for influenza-related complications.
Andrew T. Pavia MD, FAAP, FACP, FIDSA; Rachael A. Lee, MD

Influenza and the Pediatric Population

An expert discussion on prevention and treatment in the pediatric population.
Andrew T. Pavia, MD, FAAP, FACP, FIDSA; Leigh Montejo, DNP, FNP-BC
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to keep current of strategies to minimize disease burden and transmission during the 2022-2023 flu season.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print